[HTML][HTML] APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases

R Fernández-Calle, SC Konings… - Molecular …, 2022 - Springer
ApoE is the major lipid and cholesterol carrier in the CNS. There are three major human
polymorphisms, apoE2, apoE3, and apoE4, and the genetic expression of APOE4 is one of …

[HTML][HTML] Microglial TYROBP/DAP12 in Alzheimer's disease: Transduction of physiological and pathological signals across TREM2

JV Haure-Mirande, M Audrain, ME Ehrlich… - Molecular …, 2022 - Springer
TYROBP (also known as DAP12 or KARAP) is a transmembrane adaptor protein initially
described as a receptor-activating subunit component of natural killer (NK) cells. TYROBP is …

[HTML][HTML] Reconsidering the role of blood-brain barrier in Alzheimer's disease: From delivery to target

JA Sousa, C Bernardes, S Bernardo-Castro… - Frontiers in aging …, 2023 - frontiersin.org
The existence of a selective blood-brain barrier (BBB) and neurovascular coupling are two
unique central nervous system vasculature features that result in an intimate relationship …

Microglia in neuroimmunopharmacology and drug addiction

H Li, LR Watkins, X Wang - Molecular Psychiatry, 2024 - nature.com
Drug addiction is a chronic and debilitating disease that is considered a global health
problem. Various cell types in the brain are involved in the progression of drug addiction …

Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease

EL Castranio, P Hasel, JV Haure‐Mirande… - Alzheimer's & …, 2023 - Wiley Online Library
Introduction The inositol polyphosphate‐5‐phosphatase D (INPP5D) gene encodes a dual‐
specificity phosphatase that can dephosphorylate both phospholipids and phosphoproteins …

[HTML][HTML] Functional and phenotypic diversity of microglia: implication for microglia-based therapies for Alzheimer's disease

YJ Xu, NPB Au, CHE Ma - Frontiers in aging neuroscience, 2022 - frontiersin.org
Alzheimer's disease (AD) is a progressive neurodegenerative disease and is closely
associated with the accumulation of β-amyloid (Aβ) and neurofibrillary tangles (NFTs). Apart …

Human striatal glia differentially contribute to AD-and PD-specific neurodegeneration

J Xu, HL Farsad, Y Hou, K Barclay, BA Lopez… - Nature aging, 2023 - nature.com
The commonalities and differences in cell-type-specific pathways that lead to Alzheimer
disease (AD) and Parkinson disease (PD) remain unknown. Here, we performed a single …

[HTML][HTML] Synapses, microglia, and lipids in Alzheimer's disease

PJ Paasila, JA Aramideh, GT Sutherland… - Frontiers in …, 2022 - frontiersin.org
Alzheimer's disease (AD) is characterised by synaptic dysfunction accompanied by the
microscopically visible accumulation of pathological protein deposits and cellular dystrophy …

Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms …

K Honda, Y Saito, H Saito, M Toyoda, R Abe… - Neurobiology of …, 2023 - Elsevier
Abstract Apolipoprotein E4 (apoE4) is a risk factor for Alzheimer's disease (AD). Here, we
investigated brain amyloid-β (Aβ) accumulation throughout the aging process in an amyloid …

[HTML][HTML] MMP9 and TYROBP affect the survival of circulating tumor cells in clear cell renal cell carcinoma by adapting to tumor immune microenvironment

L Guo, T An, H Zhou, Z Wan, Z Huang, T Chong - Scientific Reports, 2023 - nature.com
Circulating tumor cells (CTCs) play a key role in tumor metastasis. CTCs have altered gene
expression and can survive in the bloodstream. Finding the key genes whose expression …